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Fusarium head blight (FHB), mainly caused by Fusarium
graminearum, is a devastating disease of wheat that results in
economic losses worldwide. During infection, F. graminearum
produces trichothecene mycotoxins, including deoxynivalenol
(DON), that increase fungal virulence and reduce grain quality.
Transgenic wheat expressing a barley UDP-glucosyltransferase
(HvUGT13248) were developed and evaluated for FHB re-
sistance, DON accumulation, and the ability to metabolize
DON to the less toxic DON-3-O-glucoside (D3G). Point-
inoculation tests in the greenhouse showed that transgenic
wheat carrying HvUGT13248 exhibited significantly higher
resistance to disease spread in the spike (type II resistance)
compared with nontransformed controls. Two transgenic events
displayed complete suppression of disease spread in the spikes.
Expression of HvUGT13248 in transgenic wheat rapidly and
efficiently conjugated DON to D3G, suggesting that the enzy-
matic rate of DON detoxification translates to type II resistance.
Under field conditions, FHB severity was variable; nonetheless,
transgenic events showed significantly less-severe disease phe-
notypes compared with the nontransformed controls. In addi-
tion, a seedling assay demonstrated that the transformed plants
had a higher tolerance to DON-inhibited root growth than
nontransformed plants. These results demonstrate the utility of
detoxifying DON as a FHB control strategy in wheat.
Fusarium head blight (FHB) (scab), primarily caused by
Fusarium graminearum, is a disease of wheat and barley that
results in dramatic losses of grain yield and quality (Goswami
and Kistler 2004; Kazan et al. 2012; Parry et al. 1995). During
infection, F. graminearum produces trichothecene mycotoxins,
including deoxynivalenol (DON), which facilitate disease de-
velopment and contaminate grain (Goswami and Kistler 2004).
Grain products contaminated with trichothecenes pose human
and animal health issues when consumed (Pestka 2010; Bin-
Umer et al. 2011). For this reason, the United States Food and
Drug Administration has set the advisory level of DON at 1 ppm
(mg kg
_1) in finished wheat products for human consumption
(United States Food and Drug Administration 2010). Similarly,
the European Union has established a maximum tolerance level
of 0.75 ppm for DON in food commodities for human con-
sumption (European Commission 2006). Therefore, reducing
trichothecene concentrations in grains is essential both for food
safety and in disrupting FHB development.
The two major types of FHB resistance in wheat are recognized
as type I (resistance to initial infection) and type II (resistance to
disease spread in infected spikes) (Mesterhazy 1995). Numerous
quantitative trait loci (QTL) associated with type I and II resistance
have been identified (Anderson et al. 2001; Buerstmayr et al.
2009; Waldron et al. 1999). A major QTL for type II resistance
was identified in wheat on the short arm of chromosome 3B and is
referred to asFhb1 (Anderson et al. 2001; Liu et al. 2006;Waldron
et al. 1999). Intensive breeding efforts have been established that
have resulted in incorporation of QTL into elite breeding lines;
however, the level of resistance conferred by these QTL is in-
sufficient to alone provide protection to FHB, and the mechanisms
of resistance provided by these QTL are not clear (Buerstmayr
et al. 2009). Transgenic wheat events expressing host defense
genes and DON-resistant genes have been developed, but these
have only resulted in modest reductions in disease severity (Di
et al. 2010; Mackintosh et al. 2007; Okubara et al. 2002; Shin et al.
2008). Although a recent report on host-induced gene silencing of
a chitin synthase gene in transgenic wheat showed high levels of
resistance to FHB (Cheng et al. 2015), there is a need to explore
additional genetic mechanisms that perturb the infection process,
thus resulting in improved FHB resistance.
Previous studies have shown that trichothecenes act as virulence
factors during FHB disease development by contributing to dis-
ease spread in the infected spikes. F. graminearum strains carrying
loss-of-function mutations in the TRI5 gene, which encodes the first
enzyme in the trichothecene biosynthetic pathway, resulted in the
lack of trichothecene production and reduced virulence on wheat
(Proctor et al. 1995). Noteworthy, these trichothecene-deficient
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strains of F. graminearum can infect wheat but were unable to
spread within the spike, demonstrating that trichothecenes are not
required for initial infection but that they do play an important role
in the spread of disease symptoms in the spike (Bai et al. 2002;
Desjardins et al. 1996; Jansen et al. 2005; Proctor et al. 1997).
Additional studies on the infection strategy of Fusarium spp.
revealed that the pathogen has a biotrophic growth phase for about
48 h after spore germination. Subsequently, the pathogen produces
trichothecenes and transitions to a necrotrophic strategy (Brown
et al. 2010; Kazan et al. 2012; Lysøe et al. 2011). These findings
indicate that suppression of trichothecene accumulation at early
time points may be essential for limiting FHB development. Pre-
vious work by Lemmens et al. (2005) examined a population seg-
regating for Fhb1 QTL and found that lines containing the resistant
Fhb1 allele exhibited an increased ability to conjugate DON with
glucose to the less-toxic DON-3-O-glucoside (D3G). These results
indicated that the conjugation of DON to D3G is a potential re-
sistance mechanism, and the authors proposed that Fhb1 likely
encodes for either a UDP-glucosyltransferase (UGT) or a gene that
regulates UGT activity. Taken together, this information suggests
that trichothecenes play a major role in pathogen virulence and the
identification of appropriate genes that encode for UGTs for sub-
sequent expression in transgenic plants may serve as an avenue to
reduce DON accumulation and, in turn, disease severity.
Large gene families encode UGTs in plants (Caputi et al.
2012; Ross et al. 2001). These genes function by glucosylating
plant metabolites and can also act to detoxify virulence factors
produced by pathogens. An Arabidopsis UGT (DOGT1 or
AtUGT73C5) was shown to conjugate DON at the carbon 3
position (C3-OH) group with glucose to form D3G (Poppen-
berger et al. 2003). Overexpression of AtUGT73C5 in transgenic
Arabidopsis resulted in DON resistance (Poppenberger et al.
2003). However, these same transgenic plants exhibited a dwarf
phenotype, likely due to the conjugation of brassinosteroid
brassinolide to the inactive brassinolide-23-O-glucoside
(Poppenberger et al. 2005). A barley UGT, HvUGT13248, is up-
regulated by F. graminearum infection and DON application
(Boddu et al. 2007; Gardiner et al. 2010). Functional character-
ization of HVUGT13248 showed that expression in both yeast
and Arabidopsis imparts DON resistance by converting DON to
D3G (Schweiger et al. 2010; Shin et al. 2012). In contrast to the
transgenic Arabidopsis expressing DOGT1, Arabidopsis plants
expressing HvUGT13248 did not exhibit a dwarf phenotype and
the conjugation of brassinosteroids was not observed (Shin et al.
2012). Moreover, Brachypodium distachyon possesses two UGT
homologs to HvUGT13248, which also showed resistance to
high levels of DON by formation of D3G in yeast (Schweiger
et al. 2013). These results suggest UGTs are promising genes for
increased FHB resistance in wheat.
The overall goals of this study were to develop transgenic
wheat expressing HvUGT13248 and to examine whether this
gene increases resistance to F. graminearum infection and DON.
The specific objectives of this study were i) to develop transgenic
wheat constitutively expressing HvUGT13248, ii) to evaluate
these wheat lines for resistance to FHB in the greenhouse and in
field trials, iii) to assess these wheat lines for resistance to DON,
and iv) to monitor the conversion of DON to D3G in planta.
RESULTS
Generation of transgenic wheat expressing HvUGT13248.
The plasmid, designated pZP212-HvUGT13248, carrying the
HvUGT13248 gene driven by the maize ubiquitin promoter,
coupled with its first intron (Christensen et al. 1992) (Fig. 1A)
was used for particle bombardment transformation of the
wheat cv. Bobwhite (BW) and Agrobacterium-mediated trans-
formation of the wheat cv. CBO37. The HvUGT13248 open
reading frame has a C-terminal FLAG epitope, which enables
Fig. 1. Transformation plasmid and characterization of transgenic wheat. A, The pZP212 plasmid containing the HvUGT13248 transgene (pZP212-
HvUGT13248) was used for wheat transformation. NPT II = neomycin phosphotransferase II gene; Ubi-1 pro. = maize ubiquitin-1 promoter with the first
intron; 35S pro. = Cauliflower mosaic virus 35S promoter; FLAG = FLAG-epitope tag for Western blotting. B, Southern blot analysis using 32P-dCTP labeled
NPTII gene and XbaI-digested genomic DNA. C, Western blot analysis using FLAG-epitope antibody. Events #8, #14, #15, #19, #34, and #37 were
independent transgenic lines in the Bobwhite (BW) background and BW was the nontransformed control; #1381, #1726, #1386, and #1383 were independent
transgenic lines in the CBO37 background and CBO37 was the nontransformed control.
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tracking of the HvUGT13248 protein with FLAG-epitope anti-
bodies. To this end, Western blot analysis using the FLAG-
epitope antibodies was conducted on the T1 progeny derived
from the primary transgenic events. Six BW transgenic events
(#8, #14, #15, #19, #34, and #37) and four CBO37 transgenic
events (#1381, #1726, #1386, and #1383) accumulating detect-
able HvUGT13248-FLAG protein levels were selected and were
allowed to self-pollinate (Fig. 1C). Variation in expression levels
of the transgenewas observed across the selected events, with the
nontransformed BW and CBO37 controls displaying no detect-
able signal (Fig. 1C). Coexpression of the HvUGT13248 protein
with the NPTII selectable marker (enzyme-linked immunosor-
bent assay [ELISA] assay, described below) was observed. Thus,
the NPTII ELISA assay was a convenient and reliable marker for
the presence of the active HvUGT13248 transgene and sub-
sequent determinations of HvUGT13248 transgene expression
were based on the NPTII ELISA assay.
A Southern blot analysis was conducted on T3 individuals from
the selected transgenic events to determine if they originated from
independent transformation events. Genomic DNA was digested
with the XbaI restriction endonuclease and was probed with the
full-length NPTII gene. The probe did not hybridize to BW or
CBO37 nontransformed controls, while each of the BW-derived
and the CBO37-derived transgenic events exhibited different
banding patterns, demonstrating that the transgene was success-
fully integrated into these lines and that they originated from
independent transformation events (Fig. 1B).
Evaluation of type II resistance conferred
by transgenic wheat expressing HvUGT13248.
To evaluate type II resistance in the transgenic wheat events,
we performed point inoculation experiments under greenhouse
conditions. For each screen, except for the Spring 2011 trial
when there was limited seed availability, 20 plants of each
transgenic event were grown and ELISA for the NPTII protein
was performed on each plant. Between two to 20 plants from
each transgenic event expressed the transgene, indicating that
expression was relatively stable over generations (Supple-
mentary Table S1). Plants expressing HvUGT13248 and, in
some cases, the nonexpressing siblings (UGT-) were screened
for FHB resistance. The susceptible check cv. Wheaton ex-
hibited 84.7% FHB severity on average across all three trials,
while the resistant check cv. Sumai 3 exhibited an average FHB
severity of 10.1%, indicating that the environment for disease
progression was successful and discriminative. Our results
show the transgenic events significantly reduced FHB severity
compared with the nonexpressing siblings and nontransformed
BW and CBO37 controls (Fig. 2). Compared with the non-
transformed BW control, the reduction of disease severity
across screening T1, T2, and T3 plants from the BW transgenic
events was at least 74%. Moreover, events #15 and #19 dis-
played a high degree of type II resistance in the greenhouse
assays, with negligible fungal spread within the spike, an
equivalent type II resistant phenotype to the Sumai 3 control. In a
similar fashion, the combined results from the FHB greenhouse
tests of the CBO37-derived transgenic events #1381, #1726,
#1386, and #1383 displayed significant reduction in disease se-
verity greater than 64% (Fig. 2), with CBO37 showing a more
susceptible FHB phenotype than BW. Taken together, our results
revealed that expression of HvUGT13248 in wheat translates to
enhanced type II resistance.
Transgenic wheat expressing HvUGT13248
promotes DON to D3G conversion.
To determine if the expression of HvUGT13248 in transgenic
wheat is catalyzing the conjugation of DON to D3G, hence
contributing to the observed type II resistance, we monitored
the rate of DON conjugation via quantification of DON and
D3G over time. To this end, direct DON-challenge assays on
transgenic event #19 and the corresponding BW control were
conducted. Plants from event #19 were challenged with DON
at a 2 µg per spikelet rate applied to 25 spikelets (50 µg or
169 nmol in total per spike) on the main spike per individual.
Tissues samples were taken at 1, 3, 7, 14, and 21 days after
DON challenge. DON and D3G levels were ascertained by
liquid chromatography coupled to tandem mass spectrometry
(LC-MS/MS). The conversion of DON to D3G was observed in
event #19 and the nontransformed BW. However, the conver-
sion of DON to D3G was more rapid in event #19 relative to
BW, with an average of 24% DON converted to D3G in event
#19 within the first 24 h after DON application, while there was
Fig. 2. Fusarium head blight (FHB) greenhouse screen of transgenic wheat
expressing HvUGT13248 at 21 days after point-inoculation. FHB severity
was calculated as the percentage of symptomatic spikelets per spike at 21
days after inoculation. Wheaton was the susceptible check; Sumai 3 was the
resistant check. A, Events #8, #14, #15, #19, #34, and #37 are transgenic
wheat expressing HvUGT13248 in the Bobwhite (BW) background; and
B, events #1381, #1726, #1386, and #1383 are transgenic wheat expressing
HvUGT13248 in the CBO37 background.
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only 2% DON conversion in BW. Between 1 and 3 days after
DON application, the conversion of DON toD3Gwas greater in the
nontransformed than transgenic plants, likely due to the lower level
of DON in the transgenic plants. By 21 days after challenge, re-
sidual DON levels present in the transgenic plants were only 26%
of that in BW (Fig. 3A and C). In addition, the D3G/DON ratio
trended higher in event #19 compared with BW (Fig. 3B). These
results clearly demonstrate in planta UGTactivity in the transgenic
samples leads to the enhanced conversion of DON to D3G.
Evaluation of field-based resistance conferred
by transgenic wheat expressing HvUGT13248.
Transgenic wheat expressing HvUGT13248 exhibited a high
level of type II resistance under greenhouse conditions. To gain
insight on the translation of the resistance phenotype to a field
environment, spray-inoculated experiments in mist-irrigated
plots were conducted over the 2012 to 2014 growing seasons.
Selected BW-derived transgenic lines were represented each
year, while those from CBO37-derived transgenic lines were
only in the 2013 and 2014 trials. Data on the various FHB-related
phenotypes were monitored, including FHB incidence (per-
centage of spikes with visually symptomatic spikelets of the 20
heads observed), FHB severity (percentage of symptomatic
spikelets of the total of all spikelets observed), percentage of
visually scabby kernels (VSK), and DON concentration in har-
vested grain (Table 1). In addition, D3G concentration in grain
from the 2013 and 2014 field trials was ascertained (Table 1).
Overall, FHB incidence, severity, and VSK in the BW- and
CBO37-derived transgenic lines exhibited variable responses
compared with the BW and CBO37 nontransformed controls, re-
spectively. All transgenic lines exhibited a statistically significant
reduction in FHB incidence and severity in at least one trial except
for event #1381 and VSK for at least one trial except for events #14
and #1381. Noteworthy, all BW-derived transgenic plants exhibited
a statistically significant reduction in FHB severity in all three trials
except for event #37 in 2014. Importantly, event #37 in 2012 and
2013 and event #1726 in 2013 and 2014 exhibited similar levels of
FHB severity and VSK compared with the type II resistant com-
mercial varieties Rollag and Alsen that carry the Fhb1 QTL. It is
also worth noting that most transgenic events showed significantly
reduced FHB incidence except in 2014. Taken together, our
results demonstrate that transgenic wheat expressing HvUGT13248
can reduce the level of FHB severity that is comparable to FHB-
resistant commercial varieties and the FHB incidence and
VSK can be reduced when FHB disease pressure is moderate
(e.g., 2013).
Fig. 3. Conjugation of deoxynivalenol (DON) to DON-3-O-glucoside (D3G) in transgenic wheat expressing HvUGT13248. A, DON and D3G concentrations
in Bobwhite (BW) and transgenic line #19 at each time point, from 1 to 21 days after DON application. B, Fold change of molar ratio of D3G to DON
concentrations in BW and transgenic line #19 at each time point. C, Rate of DON converted to D3G over time.
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Since HvUGT13248 conjugates DON to D3G, the expected
outcome is a lower concentration of DON, a higher concen-
tration of D3G, and a higher ratio of D3G/DON in the trans-
genic plants compared with the nontransformed controls. All
transgenic lines except #19 showed a higher ratio of D3G/DON
than nontransformed controls in at least one trial; however, we
observed several possible combinations of DON and D3G
concentration in the transgenic plantss compared with the
nontransformed controls. Consistent with our initial prediction
for just the DON and D3G concentrations were lines #14 and
#1386 in 2013, which exhibited statistically significant de-
creases in DON concentration and significant increases in D3G
concentration in the transgenic plants compared with the non-
transformed controls. We also observed significant decreases in
DON and nonsignificant changes in D3G concentration (e.g.,
lines #8, #15, and #19 in 2013; lines #1726 and #1383 in 2014),
significant decreases in both DON and D3G (e.g., line #1726
in 2013), nonsignificant changes in DON concentration and
significant increases in D3G concentration (e.g., lines # 8, #14,
#15, and #37 in 2014), and nonsignificant changes in DON and
D3G concentration (e.g., #1383 in 2013; #19 in 2014, #1381 in
2013 and 2014). These results show that HvUGT13248 conju-
gates DON to D3G in field conditions but that there are con-
siderable environmental factors that play a role in the DON and
D3G concentrations in the grain.
The three field trials provided the opportunity to assess the
protection HvUGT13248 offered in environments exhibiting
different levels of FHB pressure and to assess the relationship
between the ratio of DON and D3G concentration and disease
severity. We judged the severity of each field trial based on the
level of FHB incidence in the check lines included each year.
In the low disease environment in 2013, the transgenic plants
exhibited the lowest level of incidence, severity, and VSK.
Noteworthy, in 2013, the DON concentrations of all the trans-
genic plants were lower than the controls, and, in the BW-
derived transgenic events, the DON and D3G combined levels
Table 1. Field screening results of transgenic wheat expressing HvUGT13248a
Line Incidenceb Severityc VSKd DONe D3Ge D3G/DON D3G+DONe
2012
BW 96 ± 2 40 ± 4 26 ± 5 38 ± 5 NA NA NA
#8 76 ± 7* 15 ± 8** 18 ± 1 55 ± 4* NA NA NA
#14 89 ± 8 24 ± 2** 20 ± 4 40 ± 8 NA NA NA
#15 72 ± 6** 10 ± 2*** 9 ± 1** 27 ± 5 NA NA NA
#19 65 ± 9** 11 ± 2*** 14 ± 1* 28 ± 2 NA NA NA
#37 56 ± 9** 7 ± 2*** 9 ± 2*** 26 ± 2* NA NA NA
Rollag 91 ± 5 27 ± 3 16 ± 3 18 ± 3 NA NA NA
Sumai 3 48 ± 1 4 ± 0 4 ± 1 8 ± 3 NA NA NA
Alsen 90 ± 5 25 ± 3 16 ± 2 3 ± 7 NA NA NA
Wheaton 98 ± 1 42 ± 7 75 ± 0 59 ± 12 NA NA NA
2013
BW 91 ± 4 27 ± 5 8 ± 1 26 ± 3 8 ± 1 0.30 ± 0.02 34 ± 4
#8 74 ± 6* 11 ± 2* 5 ± 1** 12 ± 2** 15 ± 4 1.16 ± 0.23* 27 ± 6
#14 81 ± 2* 12 ± 1* 7 ± 1 18 ± 2* 17 ± 1** 0.94 ± 0.13** 35 ± 2
#15 68 ± 6* 9 ± 1** 3 ± 1*** 8 ± 1*** 8 ± 3 0.95 ± 0.34 16 ± 4*
#19 63 ± 4** 11 ± 2* 5 ± 0** 11 ± 3** 7 ± 3 0.52 ± 0.14 18 ± 6
#37 39 ± 8*** 4 ± 1** 4 ± 1** 11 ± 2** 13 ± 5 1.06 ± 0.31 24 ± 6
CBO37 83 ± 3 17 ± 3 19 ± 1 39 ± 3 22 ± 5 0.57 ± 0.12 61 ± 6
#1381 76 ± 7 15 ± 4 16 ± 1 30 ± 4 35 ± 7 1.13 ± 0.11* 65 ± 11
#1726 44 ± 9** 5 ± 1** 4 ± 1*** 8 ± 1*** 6 ± 1* 0.71 ± 0.09 14 ± 2***
#1386 55 ± 5** 7 ± 1** 11 ± 2** 27 ± 4* 56 ± 9** 2.07 ± 0.12*** 83 ± 13
#1383 74 ± 4 9 ± 2* 8 ± 2*** 28 ± 5 33 ± 7 1.16 ± 0.08** 61 ± 11
Rollag 63 ± 11 7 ± 1 5 ± 1 10 ± 1 3 ± 0 0.35 ± 0.05 14 ± 0
Sumai 3 44 ± 3 3 ± 0 2 ± 1 7 ± 2 2 ± 1 0.46 ± 0.21 10 ± 3
Alsen 75 ± 5 11 ± 1 5 ± 1 8 ± 1 2 ± 1 0.29 ± 0.10 10 ± 1
Wheaton 95 ± 3 34 ± 4 43 ± 1 29 ± 5 7 ± 2 0.22 ± 0.04 35 ± 7
2014
BW 100 ± 0 64 ± 3 22 ± 2 74 ± 16 6 ± 1 0.09 ± 0.02 81 ± 17
#8 100 ± 0 33 ± 3*** 18 ± 2 107 ± 16 21 ± 1*** 0.22 ± 0.04* 128 ± 16
#14 98 ± 3 42 ± 6** 21 ± 2 95 ± 14 21 ± 3** 0.23 ± 0.03** 115 ± 16
#15 96 ± 2 37 ± 11* 21 ± 3 75 ± 12 16 ± 2** 0.22 ± 0.02** 91 ± 14
#19 100 ± 0 47 ± 4** 24 ± 4 77 ± 10 10 ± 1 0.13 ± 0.01 87 ± 11
#37 99 ± 1 57 ± 4 20 ± 3 64 ± 9 19 ± 2** 0.30 ± 0.02*** 83 ± 12
CBO37 98 ± 1 34 ± 5 25 ± 3 111 ± 8 17 ± 2 0.16 ± 0.02 128 ± 9
#1381 91 ± 3 25 ± 4 19 ± 1 84 ± 12 20 ± 3 0.23 ± 0.01** 104 ± 14
#1726 84 ± 7 16 ± 2** 16 ± 3* 52 ± 8** 18 ± 1 0.38 ± 0.08* 70 ± 7**
#1386 95 ± 2 32 ± 3 20 ± 1 98 ± 21 25 ± 1* 0.28 ± 0.05 123 ± 20
#1383 81 ± 6* 13 ± 1** 8 ± 1** 57 ± 6** 16 ± 1 0.28 ± 0.03** 73 ± 7**
Rollag 93 ± 1 23 ± 1 15 ± 2 32 ± 8 2 ± 0 0.07 ± 0.01 34 ± 8
Sumai 3 91 ± 2 18 ± 2 9 ± 2 22 ± 4 3 ± 0 0.13 ± 0.02 25 ± 4
Alsen 93 ± 3 29 ± 3 18 ± 4 42 ± 9 4 ± 0 0.10 ± 0.03 46 ± 9
Wheaton 98 ± 3 72 ± 9 75 ± 0 107 ± 21 6 ± 0 0.07 ± 0.01 113 ± 21
a Events #8, #14, #15, #19 and #37 are transgenic wheat expressing HvUGT13248 in the Bobwhite (BW) background, and events #1381, #1726, #1386 and
#1383 are expressingHvUGT13248 in the CBO37 background. Wheaton was the susceptible check; Alsen, Rollag and Sumai 3 were type II resistant checks;
BWand CBO37 were the nontransformed controls. Values provided are the means ± standard error. *, ** and *** indicate significance at the 0.05, 0.01 and
0.001 levels compared with the BW or CBO37 nontransformed controls. NA = not available.
b Fusarium head blight (FHB) incidence, the percentage of spikes with visually symptomatic spikelets of the 20 heads observed.
c FHB severity, the percentage of diseased spikelets of the total of the 20 spikes observed.
d VSK (%): the percentage of visually scabby kernels (VSK).
e Deoxynivalenol (DON), DON-3-O-glucoside (D3G), and D3G+DON concentrations are shown in nanomoles per gram.
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were lower than those of the nontransformed BW lines, except
for transgenic event #14. In the higher disease environment in
2012, we observed a trend toward a significant reduction in
FHB incidence, FHB severity, and VSK, but the DON con-
centration in the transgenic plants compared with the control
was not significantly different. In the highest disease environ-
ment in 2014, we observed a significant decrease in FHB se-
verity of the transgenic plants, although the other disease
parameters exhibited high variation. Only transgenic line #1726
showed consistently high levels of resistance across the disease
environments, with lower FHB incidence, a higher D3G/DON
ratio, and statistically significantly lower FHB severity, VSK,
DON, and DON and D3G combined than the nontransformed
CBO37. Our results indicate a general trend for the transgenic
plants to perform best in an environment with reduced disease
pressure, although, even under high disease pressure, the
transgenic plants can confer a significant reduction in FHB
incidence, FHB severity, and VSK, but considerable variability
with regards to DON and D3G concentration is apparent.
Transgenic wheat expressing HvUGT13248
provides resistance in roots to DON.
DON is known to inhibit root elongation in Arabidopsis and
wheat (Masuda et al. 2007), so we examined the root growth
of selected HvUGT13248 events on DON-supplemented
growth medium (Fig. 4, Supplementary Figs. S1 and S2). T4
seeds of homozygous lineages derived from transgenic events
#8, #15, and #37 along with the corresponding control BW
were germinated on Murashige and Skoog (MS) medium for
24 h and were subsequently transferred to MS medium sup-
plemented with 0, 2, 5, and 10 ppm (milligrams per liter)
DON. Root growth was measured once a day from 3 to 7 days
after germination. In control treatments (0 ppm DON), root-
growth measurements for the transgenic events were not
significantly different from BW (Fig. 4). However, in plates
containing DON, root growth from the transgenic events
was significantly longer than BW (Fig. 4). Similar results
were observed in the transgenic events in the CBO37
background.
Fig. 4. Root growth of transgenic wheat lines (#8, #15, and #37) in the Bobwhite background expressing HvUGT13248 on Murashige and Skoog medium
containing 0, 2, 5, and 10 ppm deoxynivalenol (DON).
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Expression of HvUGT13248
in wheat does not alter morphology.
To determine if the expression of HvUGT13248 in wheat
resulted in morphological changes compared with the controls,
we measured the height of the transgenic wheat plants and the
controls in field trials in 2013 and 2014. Our results showed
that the transgenic plants were indistinguishable, except for
#1726 in 2013, from the controls under both field environments
(Supplementary Fig. S3).
DISCUSSION
Transgenic wheat expressing HvUGT13248
exhibit FHB resistance and does not alter morphology.
Plant UGTs have previously been demonstrated to conjugate
DON to the less toxic metabolite D3G in both yeast (Poppen-
berger et al. 2003; Schweiger et al. 2010, 2013) and Arabidopsis
(Poppenberger et al. 2003; Shin et al. 2012) systems. To address
the potential to translate these findings from model systems to
commodity crops as a means to mitigate pathogenesis of Fusa-
rium spp., we introduced HvUGT13248 into two wheat genetic
backgrounds, BW and CBO37, and subsequently phenotyped a
set of derived transgenic events under laboratory, greenhouse,
and field-based environments. The data tabulated from these
studies clearly show that transgenic wheat events expressing
HvUGT13248 had significantly lower FHB severities compared
with their respective controls, over diversified environmental
conditions and across two genetic backgrounds (Table 1; Fig. 2).
The results herein reveal HvUGT13248 expression in wheat can
lead to an equivalently high level of type II resistance to the type
II–resistant cv. Sumai 3 (Fig. 2). Previous transgenic approaches
to enhance FHB resistance in wheat included the introduction of
antifungal proteins wherein reduction in disease severity was
modest in the greenhouse, ranging from 30 to 52% (Di et al.
2010; Mackintosh et al. 2007; Shin et al. 2008). Importantly,
HvUGT13248 not only enhances the type II resistance response
but also led to significant reduction in FHB incidence, except in
2014, when disease pressure was high, which indicates that
HvUGT13248 may also contribute to the type I resistance re-
sponse by detoxifying DON at an early stage of initial infection.
Interestingly, trichothecene biosynthesis is induced during the
establishment of initial infection (Boenisch and Scha¨fer, 2011)
but not needed for initial infection (Bai et al. 2002). Thus, ad-
ditional research is required to determine the role that conjuga-
tion of DON to D3G may play in resistance to initial infection.
HvUGT13248 belongs to the glycosyltransferase gene super-
family, which includes a plethora of homologous genes in plants,
including Arabidopsis thaliana, Brachypodium distachyon,
wheat, and barley (Caputi et al. 2012; Li et al. 2001; Schweiger
et al. 2010, 2013). The Arabidopsis DOGT1 gene is capable of
conjugating DON to D3G, and overexpression of DOGT1 in
Arabidopsis resulted in increased tolerance against DON and 15-
ADON (15-acetylated DON) (Poppenberger et al. 2003). However,
DOGT1 also catalyzes glucoside conjugation with brassinosteroids,
resulting in a dwarf phenotype in transgenic Arabidopsis plants
(Poppenberger et al. 2005). UnlikeDOGT1,HvUGT13248 does not
produce brasinosteroid glucosides in Arabidopsis plants, and the
morphology of the transgenic Arabidopsis was similar to the non-
transformed controls (Shin et al. 2012). Consistent with the previous
results in Arabidopsis, our results showed that expression of
HvUGT13248 in wheat, with the exception of #1726 in 2013, does
not alter plant height.
Rapid and large amount of conjugation
of DON to D3G results in type II resistance.
The underlying mechanism associated with the observed
enhanced type II resistance imparted by expression of the
HvUGT13248 in wheat is enzymatic activity leading to the
increased conversion rate of DON to D3G (Fig. 3). Although
DON glycosylation is a common detoxification strategy in
cereal crops and D3G is identified in naturally contaminated
fields (Berthiller et al. 2005, 2009), our results show that the
rate and amount of conjugation, especially at the early stage of
infection, is important for resistance. In our feeding experi-
ment, BW converted DON to D3G; however, transgenic line
#19 converted a larger portion of DON to D3G in the first 24 h.
In our field tests, both nontransformed controls BWand CBO37
accumulated higher levels of D3G compared with resistant
checks (Sumai 3, Rollag, and Alsen), and even the susceptible
check Wheaton showed the ability to convert DON to D3G.
However, in all these lines, the ratio of D3G/DON is much
lower than all of the transgenic lines. These results are con-
sistent with previous reports of transgenic yeast and Arabi-
dopsis expressing HvUGT13248 that showed higher resistance
to DON in the growth media and, ultimately, higher ratios of
D3G/DON compared with the nontransformed controls
(Schweiger et al. 2010; Shin et al. 2012).
Previous attempts to provide FHB resistance through tricho-
thecene metabolism via a detoxification route were largely
ineffective. The Tri101 gene encodes an enzyme that catalyzes
the acetylation of the hydroxyl group at the C3-OH of tricho-
thecene precursors to reduce toxicity (McCormick et al. 1999).
Transgenic tobacco plants expressing the F. sporotrichioides–
derived Tri101 gene (FsTri101) showed increased tolerance to
trichothecenes (Muhitch et al. 2000). However, when FsTri101
was overexpressed in transgenic wheat (Okubara et al. 2002), the
derived transgenic plants only showed partial type II resistance
after point inoculation under greenhouse conditions.
D3G is considered a ‘masked’ trichothecene (Berthiller et al.
2005), given that D3G is not monitored during routine assays
for trichothecenes but can be converted back to DON by the gut
microflora of mammals (Berthiller et al. 2011). Thus, although
D3G is less phytotoxic than DON (Poppenberger et al. 2003),
the accumulation of D3G in grain is still considered a potential
health issue. However, the rapid conjugation of DON to D3G
during the early stages of infection may reduce overall fungal
load, which in turn may result in reduced DON and D3G in
grain. For example, the most resistant transgenic events,
#37 and #1726, both accumulated lower total toxin levels
(DON+D3G) in the 2013 field trial, as compared with the
corresponding nontransformed controls (Table 1).
In summary, our results show that transgenic wheat expressing
HvUGT13248 is an intriguing option for further exploration with
the goal to detoxify DON and control FHB.
MATERIALS AND METHODS
Plant materials.
The spring wheat cultivars Alsen, Sumai 3, Rollag, Wheaton,
BW, and CBO37 were used for the experiments. BWand CBO37
were used for transformation experiments. Wheaton and CBO37
are spring wheat cultivars that are highly susceptible to FHB.
BW is a spring wheat cultivar that exhibits moderate suscepti-
bility. Alsen and Rollag are spring wheat cultivars carrying the
Fhb1 QTL inherited from Sumai 3 and exhibit type II resistance
and are moderately resistant. Sumai 3 is a Chinese cultivar that
exhibits high levels of type II FHB resistance.
Plant transformation vector and wheat transformation.
The 1,452-bp barley UDP-glucosyltransferase (HvUGT13248)
gene containing a carboxyl-terminal FLAG-tag sequence was
cloned into the pENTERTM/D TOPO vector (Shin et al. 2012) and
was then inserted into the binary expression plasmid pIPKb002
(Himmelbach et al. 2007), using the Gateway LR recombination
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reaction. The Ubi1 promoter forward 59-GGGAAGCTTGGCCT
TACTAGGCTGCAGTG-39 and nopaline synthase (NOS) termi-
nator reverse 59-CCCGGTACCCGCGTCGAGCGATCTAGTA-39
primers were used for the HvUGT13248 polymerase chain reaction
(PCR) amplification including the Ubi1 promoter and NOS termi-
nator. The 2.9-kb PCR product was digested and cloned into the
unique HindIII and KpnI sites of the vector pZP212. The pZP212
plasmid contains the NPTII gene driven by the Cauliflower mosaic
virus 35S promoter and terminated by the NOS gene from Agro-
bacterium tumefaciens (Hajdukiewicz et al. 1994). The spring
wheat cultivar BW was used for transformation by particle gun
bombardment method. The transformation protocols, including
particle gun bombardment of embryos, tissue culture selection, and
plant regeneration, were conducted according to the protocol de-
scribed by Mackintosh and colleagues (2006). The CBO37-derived
transgenic lines were produced using Agrobacterium-mediated
transformation according to Cheng and colleagues (1997).
Characterization of transgenic wheat
expressing HvUGT13248.
For Southern blot analysis of transgenic wheat carrying the
HvUGT13248 gene, genomic DNA (10 µg) was digested with
endonuclease XbaI, was separated on a 1% agarose gel, and
was transferred onto Hybond N+ membranes (Amersham Bio-
sciences, Piscataway, NJ, U.S.A.). The NPTII gene probe
(795 bp) was derived from a PCR-amplified product. The for-
ward 59-ATGATTGAACAAGATGGATTG-39 and reverse 59-
TCAGAAGAACTCGTCAAG-39 primers were used for theNPTII
gene probe PCR amplification. The probe sequence was labeled
with 32P dCTP using the Prime-a-Gene labeling system (Promega,
Madison, WI, U.S.A.), following the manufacturer’s instructions.
The radiolabeled NPTII gene was used as a probe for the hybrid-
ization, and the subsequent banding patterns were visualized using
autoradiography.
For Western blot analysis, protein was extracted by grinding
leaf tissues in extraction buffer (2% sodium dodecyl sulfate
[SDS], 60 mM Tris-HCl [pH 6.8], 14.4 mM b-mercaptoethanol,
10% glycerol, and 0.1% [wt/vol] bromophenol blue) and cell
debris was removed by centrifugation. Total protein concentra-
tion was determined using Bio-Rad reagent (Bio-Rad, Hercules,
CA, U.S.A.), with bovine serum albumin as a standard. Protein
extracts (10 µg for BW transgenic lines and 15 µg for CBO37 lines)
were separated by SDS-polyacrylamide electrophoresis (12%
acrylamide) and were transferred to polyvinylidene diflouride
transfer membrane (Amersham Biosciences, Piscataway, NJ, U.S.
A.). A DYKDDDK tag horseradish peroxidase–conjugated antibody
recognizing the FLAG-tag sequence (Cell Signaling Technology,
Beverly, MA, U.S.A.) was used to detect the HvUGT13248-Flag
protein at a 1:3,000 dilution. The protein was visualized using the
SuperSignal West Pico chemiluminescent substrate (Thermo
Scientific, Pierce Biotechnology, Rockford, IL, U.S.A.).
Greenhouse screening
of transgenic lines against F. graminearum.
Plants were sown into SunshineMVP growth medium (Sun Gro
Horticulture, Agawam, MA, U.S.A.) in 6-inch square plastic pots
in a greenhouse. Seeds from each transgenic linewere planted four
seeds per pot. Nontransformed controls (BW, CBO37, Sumai 3,
and Wheaton) were also planted four seeds per pot. Plants were
fertilized with 1 teaspoon of Osmocote (14-14-14 N-P-K; Scotts
Company, Marysville, OH, U.S.A.) fertilizer per pot at the three-
leaf stage. ELISA kits (Agdia Inc., Elkhart, IN, U.S.A.) for the
NPTII antibody were used to identify plants expressing the
transgene. At anthesis, one floret of a central spikelet of the main
spike was inoculated with 10 µl of F. graminearummacroconidial
suspension (105 macroconidia per milliliter). Inoculated spikes
were covered with transparent plastic bags for 3 days. FHB disease
severity was determined as the percentage of spikelets with disease
symptoms on the inoculated spikes at 21 days after inoculation
(dai). For statistical analysis, Student’s t tests were used to com-
pare each transgenic event to the parental nontransformed con-
trols. All analysis was performed with Microsoft Excel 2013
(Microsoft Corp., Redmond, WA, U.S.A.).
Conversion of DON to D3G in planta.
For transgenic event #19 in the BW background and the non-
transformed BW control, 10 µl of DON (0.2 µg µl
_1) was in-
troduced, at anthesis between the palea and lemma, in each of 25
florets on the main spike of each plant. In this manner, each spike
received 50 µg of DON. Three spikes of each genotype were bulk-
sampled at 1, 3, 7, 14, and 21 dai. Three biological replications
were conducted for each time point for each genotype. The spikes
for each replication were ground in liquid nitrogen, and metabo-
lites were extracted in 4× volume of extraction solvent
(CH3CN/H2O/Hac, 79:20:1). DON and D3G levels were ascer-
tained by LC-MS/MS according to Vendl et al. (2009).
Field screening of transgenic lines against F. graminearum.
Field tests were conducted in the summers of 2012, 2013, and
2014 at the University of Minnesota Agricultural Experiment
Station (UMore Park) in Rosemount, MN, U.S.A. Seeds for the
transgenic events included in the field trials were obtained
from ELISA-positive plants in the previous generation. Non-
transformed controls (BW, CBO37, Rollag, Wheaton, and
Sumai 3) were also planted. Entries were arranged in a ran-
domized complete block design with four replications. All the
lines were spray-inoculated twice. The first inoculation was
applied at anthesis. The second inoculation was made 3 days
after the initial application for each plot. The inoculum was a
composite of 30 to 39 F. graminearum isolates at a concen-
tration of 100,000 macroconidia per milliliter. The inoculum
was applied using a CO2-powered sprayer fitted with a SS8003
TeeJet spray nozzle with an output of 10 ml per second, at a
working pressure of 275 kPa. Mist-irrigation was applied from
the first inoculation through disease assessment to facilitate
FHB development. FHB incidence and severity were assessed
visually 19 to 27 dai on 20 arbitrarily selected heads per plot.
FHB incidence was determined by the percentage of spikes
with visually symptomatic spikelets of the 20 heads observed.
FHB severity was determined as the percent symptomatic
spikelets of the total of all spikelets observed. Approximately
60 heads were hand harvested from each plot at maturity, were
threshed, and the seeds were cleaned manually. The cleaned
grain samples were then used to determine the percentage of
VSK (Jones and Mirocha 1999). DON concentrations in the
2012 field trial was conducted by gas chromatography-MS
(Fuentes et al. 2005). DON and D3G concentrations of the grain
samples in the 2013 and 2014 trials were measured using
LC-MS/MS (Vendl et al. 2009).
In the 2013 and 2014 field trials, plant height wasmeasured in the
BW and CBO37 transgenic plants and nontransformed controls.
Root growth assay.
Surface-sterilized wheat seeds of the nontransformed BW
and CBO37 controls and transgenic events #8, #15, #37, #1381,
#1726, #1386, and #1383 expressing HvUGT13248were plated
on MS growth medium to germinate. One day after germina-
tion, seven seedlings of each genotype were transferred to a
square petri dish with MS medium containing DON. For BW
transgenic plants and the BW nontransformed control, the
seedlings were plated on 0, 2, 5, or 10 ppm DON, and, for the
CBO37 transgenic plants and CBO37 nontransformed control,
the seedlings were plated on 0, 2, and 5 ppm DON. Three
replicate plates of each DON concentration were used. The
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plates were positioned vertically under white light at room
temperature. Pictures were taken of the plates every day from
3 days after germination. Root growth of seedlings was determined
by measuring the longest root of each seedling from the photos,
using the ImageJ program (Rasband, W.S.; ImageJ, U. S. National
Institutes of Health, Bethesda, Maryland, U.S.A.).
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Supplementary Figure S1. Bobwhite (BW) and transgenic lines #8, #15, and 
#37 expressing HvUGT13248 grown on MS medium plates with 0 and 2 ppm 
DON at 5 days after germination (DAG). Scale bars = 4cm. 
 
 
 
Supplementary Figure S2. Root growth of CBO37 and CBO37 transgenic 
lines #1381, #1726, #1386 and #1383 expressing HvUGT13248 on MS 
medium containing 0, 2 and 5 ppm DON.  
 
 
 
Supplementary Figure S3. Transgenic wheat expressing HvUGT13248 does 
not dramatically alter plant height. Transgenic lines #8, #14, #15, #19 and #37 
are in the Bobwhite (BW) background, and transgenic lines #1381, #1726, 
#1386 and #1383 are in the CBO37 background.  
 
Supplementary Table S1. FHB severity of transgenic wheat expressing 
HvUGT13248 in greenhouse point-inoculation tests. 
 2012 Spring 2011 Fall 2011 Spring Ave. 
Red. 
Line 
No
. Sev. 
Red
. 
No
. Sev. 
Red
. 
No
. Sev. Red. 
BW 20 65 ± 9 NA 20 52 ± 9 NA 12 39 ± 12 NA NA 
#8 20 13 ± 4*** 80% 19 20 ± 4** 61% 8 7 ± 1* 82% 74% 
#14 19 19 ± 6*** 70% 16 7 ± 1*** 86% 8 7 ± 1* 82% 80% 
#14 (UGT-)    4 51 ± 21  4 36 ± 22   
#15 20 6 ± 0*** 91% 20 6 ± 0*** 88% 7 6 ± 0* 85% 88% 
#15 (UGT-)       4 53 ± 27   
#19 16 6 ± 0*** 91% 11 6 ± 0** 87% 2 6 ± 0 85% 88% 
#19 (UGT-) 4 76 ± 24  4 67 ± 22  8 53 ± 14   
#34 7 6 ± 0*** 91% 14 16 ± 7** 68% 4 7 ± 0 83% 81% 
#37 20 6 ± 0*** 91% 20 6 ± 0*** 88% 8 18 ± 12 55% 78% 
CBO37 20 91 ± 5 NA 19 100 ± 0 NA      NA 
#1381 8 23 ± 11*** 74% 17 20 ± 5*** 80%      77% 
#1381 (UGT-) 1 100  3 67 ± 21      
#1726 19 26 ± 7*** 72% 20 9 ± 2*** 91%      81% 
#1386 13 18 ± 7*** 80% 20 20 ± 5*** 80%      80% 
#1383 19 28 ± 8*** 69% 13 41 ± 11*** 59%       64% 
#1383 (UGT-)    6 98 ± 2      
Sumai 3 36 8 ± 3   35 13 ± 4   11 9 ± 4     
Wheaton 40 85 ± 5   34 83 ± 5   12 87 ± 7     
 
No.: number of plants examined in the disease screen; Sev.: FHB severity shown as the 
percentage of symptomatic spikelets in the inoculated spikes; Red.: percent disease 
reduction rate as compared to the corresponding non-transformed controls (BW or 
CBO37); Ave. Red.: average of the FHB severity reduction of three disease screens of 
the BW transgenic lines and two screens of the CBO37 transgenic lines.  
Events #8, #14, #15, #19, #34 and #37 are BW transgenic lines, and #1381, #1383, 
#1386 and #1726 are CBO37 transgenic lines. Sumai 3 was the resistant check, and 
Wheaton was the susceptible check. Values provided are the means ± standard error. 
*, ** and *** indicate significance at the 0.05, 0.01, and 0.001 levels compared with the 
non-transgenic BW control (Student’s t test). 
UGT-, indicates the individuals that segregated for the lack of HvUGT13248 
expression. 
 
